Association of leukocyte telomere length with the risk of digestive diseases: A large-scale cohort study

被引:0
|
作者
Yang Hongqun [1 ]
Chen Lanlan [2 ]
Liu Yahui [1 ]
机构
[1] The Secondary Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin, China
[2] The First Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin,
关键词
Telomere shortening; Digestive system diseases; Leukocyte telomere length; Gastrointestinal diseases; Hepatobiliary diseases;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Leukocyte telomere length (LTL) shortening, a biomarker of telomere attrition, has been linked to multiple diseases. However, the relationship between LTL and digestive diseases remains uncertain. This study aimed to investigate the association between LTL and the risk of digestive diseases.Methods: A cohort analysis of over 500,000 participants from the UK Biobank (UKB) between 2006 and 2021 was conducted to estimate the associations of LTL with more than 90 common digestive diseases. LTL was quantified using multiplex quantitative polymerase chain reaction, and cases of each disease were determined according to inpatient and primary care data. Multivariable Cox proportional hazards regression analysis was used to evaluate the associations of LTL with the risk of digestive diseases. Furthermore, such associations were also evaluated after stratification by sex and ethnicity.Results: After a mean follow-up time of 11.8 years, over 20International Classification of Diseases, 10th Revision (ICD-10) codes were showed to be associated with telomere attrition. LTL shortening is associated with an increased risk of several digestive diseases, including gastroesophageal reflux disease (K21: hazard ratio [HR] = 1.30, 95% confidence interval [95% CI]: 1.19–1.42), esophageal ulcer (K221: HR = 1.81, 95% CI: 1.22–2.71), Barrett’s esophagus (K227: HR = 1.58, 95% CI: 1.14–2.17), gastritis (K29: HR = 1.39, 95% CI: 1.26–1.52), duodenal ulcer (K26: HR = 1.55, 95% CI: 1.14–2.12), functional dyspepsia (K30X: HR = 1.36, 95% CI: 1.06–1.69), non-alcoholic fatty liver disease (NAFLD) (K760: HR = 1.39, 95% CI: 1.09–1.78), liver cirrhosis (K74: HR = 4.73, 95% CI: 3.27–6.85), cholangitis (K830: HR = 2.55, 95% CI: 1.30–5.00), and hernia (K43: HR = 1.50, 95% CI: 1.17–1.94; K44: HR = 1.29, 95% CI: 1.17–1.42). The risk of rectal polyps (K621: HR = 0.77, 95% CI: 0.63–0.92) decreased per unit shortening of LTL.Conclusions: This study suggests that LTL shortening is associated with an increased risk of most digestive diseases except for rectal polyps. These findings may provide some clues for understanding the pathogenesis of digestive diseases.
引用
收藏
相关论文
共 50 条
  • [41] Predicted Leukocyte Telomere Length and Risk of Myeloid Neoplasms
    Poynter, Jenny
    Kelley, Spencer
    Marcato, Marina
    Langer, Erica
    Hooten, Anthony J.
    Stimson, Mary Rachel
    Roesler, Michelle A.
    Nguyen, Phuong L.
    Cioc, Adina
    Warlick, Erica D.
    Pankratz, Nathan
    BLOOD, 2019, 134
  • [42] Leukocyte telomere length and risk of gastric cardia adenocarcinoma
    Liu, Yang
    Lei, Tianshui
    Zhang, Nasha
    Zheng, Yan
    Kou, Peisi
    Shang, Shuheng
    Yang, Ming
    SCIENTIFIC REPORTS, 2018, 8
  • [43] Leukocyte telomere length and risk of gastric cardia adenocarcinoma
    Yang Liu
    Tianshui Lei
    Nasha Zhang
    Yan Zheng
    Peisi Kou
    Shuheng Shang
    Ming Yang
    Scientific Reports, 8
  • [44] Leukocyte Telomere Length and Risk of Papillary Thyroid Carcinoma
    Li, Ji
    An, Changming
    Zheng, Haitao
    Lei, Tianshui
    Zhang, Nasha
    Zheng, Yan
    Yang, Ming
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (07): : 2712 - 2718
  • [45] Prediagnosis Leukocyte Telomere Length and Risk of Ovarian Cancer
    Yang, Meng
    Prescott, Jennifer
    Poole, Elizabeth M.
    Rice, Megan S.
    Kubzansky, Laura D.
    Idahl, Annika
    Lundin, Eva
    De Vivo, Immaculata
    Tworoger, Shelley S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (03) : 339 - 345
  • [46] Predicted leukocyte telomere length and risk of myeloid neoplasms
    Sullivan, Shannon M.
    Cole, Ben
    Lane, John
    Meredith, John J.
    Langer, Erica
    Hooten, Anthony J.
    Roesler, Michelle
    McGraw, Kathy L.
    Pankratz, Nathan
    Poynter, Jenny N.
    HUMAN MOLECULAR GENETICS, 2023, 32 (20) : 2996 - 3005
  • [47] Immune-mediated inflammatory diseases and leukocyte telomere length: A Mendelian randomization study
    Liu, Meiling
    Luo, Ping
    Liu, Lihua
    Wei, Xianping
    Bai, Xue
    Li, Jicui
    Wu, Linlin
    Luo, Manyu
    FRONTIERS IN GENETICS, 2023, 14
  • [48] Leukocyte telomere length as an aging marker and risk factor for human age-related diseases
    Maximov V.N.
    Malyutina S.K.
    Orlov P.S.
    Ivanoschuk D.E.
    Voropaeva E.N.
    Bobak M.
    Voevoda M.I.
    Advances in Gerontology, 2017, 7 (2) : 101 - 106
  • [49] Risk relationship between leukocyte telomere length and constipation: a Mendelian randomization study
    Chi, Zhenfei
    Bai, Xuesong
    Zhang, Zhe
    FRONTIERS IN MEDICINE, 2023, 10
  • [50] A prospective study of leukocyte telomere length and risk of phobic anxiety among women
    Ramin, Cody
    Wang, Wei
    Prescott, Jennifer
    Rosner, Bernard
    Simon, Naomi M.
    De Vivo, Immaculata
    Okereke, Olivia I.
    PSYCHIATRY RESEARCH, 2015, 230 (02) : 545 - 552